2.Clinical Analysis of Pulmonary Fungal Infection in 40 Children in Intensive Care Unit
xiao-fang, CAI ; ji-min, SUN ; wen-bin, LI
Journal of Applied Clinical Pediatrics 2006;0(16):-
Objective To investigate the risk factors of pulmonary fungal infection in intensive care unit(ICU),and discuss the strategy of prevention and treatment.Methods Forty children with pulmonary fungal infection in ICU of Wuhan Children's Hospital from Jan.2003 to Jan.2007 were analyzed retrospectively,including primarily diseases,application of antibiotics,adrenal cortical hormone and virulence operation,therapy and turnover.Results All children were accepted the therapies of broad spectrum antibiotics and glucocorticoids for long time before definite diagnosis of pulmonary fungal infection.Seventy-five percent children were received invasive operations or therapies.Their average time of stayed in hospital was 37.8 d.The clinical symptoms and imaging examinations were untypical.Blastomyces albicans was the main pathogen.After the antifungal agents and supportive treatment used in time,35 cases(87.5%) were cured and 5 cases(12.5%) died.Conclusions The major risk factors of children pulmonary fungal infection are long-time use of broad spectrum antibiotics and glucocorticoids.The pulmonary fungal infection can decrease by rational use of broad spectrum antibiotics and glucocorticoids,decreasing the unnecessary invasive operations,strengthening the supportive therapies of micro-ecosystem,and applying the antifungal agents in time.
3.Protective Effect of Hyperoxia Liquid on Multiple Organ Damage during Ischemic Reperfusion Injury in Infants with Muggy Syndrome
xiao-fang, CAI ; ji-min, SUN ; wen-bin, LI
Journal of Applied Clinical Pediatrics 2006;0(18):-
0.05).But after the treatment,there were significant increases in pa(O2),SaO2 and PCIS(Pa0.05).Conclusions Early application of hyperoxia liquid could decrease multiple organ anoxia and the damage of lipid peroxidation.It has obviously protective effects on multiple organ damage during ischemic reperfusion in infants with muggy syndrome.
4.A review of the expression and activity of drug metabolism enzymes in tumorous cells.
Wen-jing XIAO ; Guang-ji WANG ; Ji-ye A
Acta Pharmaceutica Sinica 2014;49(10):1377-1386
Tumorous cells are characterized by distinctive metabolic reprogramming and living conditions. Understanding drug metabolizing features in tumor cells will not only favor the estimation of metabolic rate, elimination half life and the assessment of potency, but also facilitate the optimal design of anti-tumor drugs/prodrugs. This article reviewed the expression and activity features of major drug metabolizing enzymes (DMEs) in solid tumorous tissues, such as liver, intestine, breast and lung, and the difference from the correspondingly normal tissues, exemplified by the metabolic properties of some classic antitumor-agents in tumorous tissues. In combination with the data retrieved in vitro tumor cell lines, we discussed the similarities and differences of DMEs expression and function between tumor tissues (in vivo) and tumor cells (in vitro), and proposed the possible factors that cause the differences.
Antineoplastic Agents
;
pharmacokinetics
;
Cell Line, Tumor
;
Humans
;
Inactivation, Metabolic
;
Liver
;
metabolism
;
Neoplasms
;
enzymology
;
Prodrugs
;
pharmacokinetics
6.Construction and evaluation of hepatitis C virus (HCV) DNA vaccine containing E_2-gAD fusion gene
Bo WEN ; Yao DENG ; Wen-Jie TAN ; Xiao YING ; Ji-Ming GAO ; Li RUAN
Chinese Journal of Experimental and Clinical Virology 2010;24(1):53-55
Objective To rational design HCV DNA vaccine candidates and evaluate their specific immunity to HCV in mice. Methods We design to construct two DNA vaccine candidates, one consists of E_2 (the envelope glycoprotein 2 of HCV) gene only, the second consists of E_2-gAD (Globular Domain of Human Adiponectin) fusion gene via overlapping PCR. Confirm the expression of the DNA vaccines by Western blotting, and then vaccinated by injection of DNA vaccines with gene electrotransfer (GET) in BALB/c mice. The immune response was measured by IFN-gamma ELISPOT. Results The DNA vaccine candidate consists of E_2-gAD could effectively express in vitro , and it could induced a higher anti-HCV T cell response in mice than the one consists of E_2 only. Conclusion The HCV DNA vaccine consists of E_2-gAD fusion can increase the immunity of the E_2 to some extend, and the research paved a way to develop and optimize the novel HCV DNA vaccine.
8.Poroid hidradenoma: a case report.
Yang GUAN ; Yin XIAO ; Hua-an JI ; Chou-wen XUE ; Peng LI
Chinese Journal of Pathology 2006;35(6):378-379
Adenoma, Sweat Gland
;
pathology
;
Adult
;
Female
;
Humans
;
Immunohistochemistry
;
Leg
;
pathology
;
Skin Neoplasms
;
pathology
9.Design, synthesis and biological evaluation of novel 3-(2-oxo-2-substituted acetamido)benzamides as PARP-1 inhibitors.
Yu-wen YIN ; Ming JI ; Ran CAO ; Xiao-guang CHEN ; Bai-ling XU
Acta Pharmaceutica Sinica 2015;50(6):738-745
Poly(ADP-ribose)polymerase-1 (PARP-1) plays a significant role in the DNA repair process by catalyzing the transfer of ADP-ribose from NAD+ to its receptors. It is a promising anticancer drug target and many PARP-1 inhibitors have been developed and used in the clinical trial. In this work, a series of 3-(2-oxo-2-substituted acetamido)benzamides have been synthesized and their inhibitory activities against PARP-1 were evaluated. Of all the tested compounds, six compounds displayed inhibitory activities with IC50 values ranging from 0.23 to 5.78 µmol.L-1 . The binding pose of compound 5a was predicted using molecular docking to facilitate further structural modification.
Antineoplastic Agents
;
Benzamides
;
chemistry
;
DNA Repair
;
Drug Design
;
Humans
;
Molecular Docking Simulation
;
Poly(ADP-ribose) Polymerase Inhibitors
;
chemical synthesis
;
chemistry
;
Poly(ADP-ribose) Polymerases
10.Expression and Clinical Implications of Preferentially Expressed Antigen of Melanoma Gene in Children with Acute Leukemia
bao-xi, ZHANG ; jing-lu, JI ; xiao-qing, ZHAO ; wen-jie, GUO
Journal of Applied Clinical Pediatrics 2006;0(20):-
0.05),but the expression in controls were negative.The expression levels of PRAME gene at remission was decreased obviously,but increased again when the patients relapsed.Conclusions Expression of PRAME gene has a high level in childhood acute leukemia.The dynamic changes are closely related with the prognosis.It can be regarded as a candidate for detecting minimal residual disease in acute leukemia,and may have important implications for estimating the prognosis and guiding the chemical therapy.